MedPage Today) — CHICAGO — Adverse event risks varied across biologics used by asthma patients, an analysis of data submitted to the FDA Adverse Event Reporting System (FAERS) showed.
In comparing relative number of reports from 2004-2024…
Adverse Event Risks Vary Among Asthma Biologics, FDA Data Show

Leave a Comment Leave a Comment
